Biopharma PEG Expands Monodispersed Azide-PEG Portfolio to Advance Bioconjugation and Drug Delivery Research
Watertown, MA — October 21, 2025 — Biopharma PEG Scientific Inc., a leading manufacturer of high-purity polyethylene glycol (PEG) derivatives, today announced the expansion of its monodispersed azide-PEG product line to meet growing demand across bioconjugation, antibody-drug conjugate (ADC) linker synthesis, and nanoparticle surface engineering.
The company’s monodispersed N₃-PEG series is optimized for CuAAC and SPAAC click chemistry, ensuring precise molecular control and reproducible conjugation performance. These PEG derivatives are used in ADC linker development, imaging probe design, biomaterial modification, and gene or drug delivery platforms.
“We can supply from milligram to 100-kilogram scale with GMP-standard manufacturing capability,” said Sonia Lee, Business Development at Biopharma PEG. “Our team includes some of the most qualified synthetic and medicinal chemists in the field, equipped with advanced analytical instruments to ensure consistency and quality across every batch.”
Biopharma PEG’s in-stock azide-PEGs range from N₃-PEG3 to N₃-PEG24, with available functional groups including –NH₂, –OH, –COOH, and multi-arm configurations. Each compound undergoes thorough characterization and quality control to meet the requirements of research and process development.
With scalable infrastructure and GMP-compliant production, Biopharma PEG continues to serve as a trusted partner for the global pharmaceutical and biotechnology industries, providing high-quality PEG derivatives from R&D lab supply to commercial-scale manufacturing.
For more information or to request specifications, visit:
https://www.biochempeg.com/product/551/
About Biopharma PEG Scientific Inc.
Biopharma PEG Scientific Inc. (Watertown, MA, USA) specializes in the design and manufacture of monofunctional, homobifunctional, and heterobifunctional PEG derivatives for use in pharmaceutical and biotechnological applications. With deep expertise in PEG chemistry and GMP-standard production, the company supports projects in drug delivery, diagnostics, bioconjugation, and advanced material development.